Evidence map›Paper›PMID 37533944›Full record

ArticleEcancermedicalscience2023

Circulating natural killer cells and their association with breast cancer and its clinico-pathological characteristics.

Homian N'da Marcelin, Romuald S Dasse, Richard O Yeboah, Agnès D Tariam, Arsène G Z Kagambega, Akandji M Oseni, Y K K Kouassi, Michel A Bilé, Moctar Toure, Monica Thakar and 2 more

Open access · goldAbstract read
In one paragraph

Article in Ecancermedicalscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Homian N'da MarcelinDepartment of Oncology, Centre Hospitalier Universitaire de Treichville, 7XVV+5P4, Abidjan, Côte d'Ivoire.
Romuald S DasseDepartment of Immunology, Centre Hospitalier Universitaire de Cocody, BP V 3, Abidjan, Côte d'Ivoire.
Richard O YeboahDepartment of Immunology, Centre Hospitalier Universitaire de Cocody, BP V 3, Abidjan, Côte d'Ivoire.
Agnès D TariamDepartment of Immunology, Centre Hospitalier Universitaire de Cocody, BP V 3, Abidjan, Côte d'Ivoire.
Arsène G Z KagambegaDepartment of Oncology, Centre Hospitalier Universitaire de Treichville, 7XVV+5P4, Abidjan, Côte d'Ivoire.
Akandji M OseniDepartment of Oncology, Centre Hospitalier Universitaire de Treichville, 7XVV+5P4, Abidjan, Côte d'Ivoire.
Y K K KouassiDepartment of Oncology, Centre Hospitalier Universitaire de Treichville, 7XVV+5P4, Abidjan, Côte d'Ivoire.
Michel A BiléDepartment of Oncology, Centre Hospitalier Universitaire de Treichville, 7XVV+5P4, Abidjan, Côte d'Ivoire.
Moctar ToureDepartment of Oncology, Centre Hospitalier Universitaire de Treichville, 7XVV+5P4, Abidjan, Côte d'Ivoire.
Monica ThakarThe Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Innocent AdoubiDepartment of Oncology, Centre Hospitalier Universitaire de Treichville, 7XVV+5P4, Abidjan, Côte d'Ivoire.
Darya KizubUniversity of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
University Hospital Medical Center at Treichville · CICentre Hospitalier Universitaire de Cocody · CIFred Hutch Cancer Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Natural killer (NK) cells play a critical role in cancer immunosurveillance and hold promise as both therapies and prognostic markers in advanced disease. We explore factors that may influence NK cell concentration in the peripheral blood of women with breast cancer in Côte d'Ivoire compared to healthy controls and implications for future research in our context. Methods: In this cross-sectional case-control study, blood samples were taken from 30 women diagnosed with breast cancer within 6 months of diagnosis and fifteen healthy women at University Teaching Hospital [Centre Hospitalier Universitaire (CHU)] Treichville in Abidjan, Côte d'Ivoire, from March to September 2018. The blood draw could take place at any time following diagnosis and through treatment. Demographic and clinical data were collected. NK cells were isolated, stained, analysed and counted using the flow cytometer at the Department of Immunology at CHU of Cocody. All p-values were two-sided. Results: Mean age among 30 women with breast cancer was 49 years old compared to 45 years old for 15 controls ( Conclusion: Although we did not find an association between NK cell concentration, cancer characteristics or treatment, our results be limited by the small sample size and timing of blood draw. Our next steps include a larger study to explore circulating NK cells prior to any treatment and NK cell infiltration within breast cancer tumour and correlating this with response to treatment and prognosis.

Indexed as

breast cancernatural killer (NK) cellstreatment

Identifiers

PMID37533944
PMCPMC10393315
OpenAlexW4382986047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.